 |
|||||||||||||||
|
|
|||||||||||||||
|
 |
|||
| Spring Meeting Trial Reports: 2011 / 2010 / 2009 | |||
| ID | Study Title | Status | |
| IND.200 | A Phase II Study of SB939 in Patients with Translocation-Associated Recurrent/Metastatic Sarcomas MORE... | Closed | |
| SR.2 | A Phase III Study of Pre-Operative External Beam Radiotherapy Compared to Post-Operative External Beam Radiotherapy in the Local Management of Curable Extremity Soft Tissue Sarcoma | Permanently Closed | |
|
SR.3 EORTC 62931 |
Randomized Phase III Trial of Adjuvant Chemotherapy with High-Dose Doxorubicin Ifosfamide and Lenograstim in High Grade Soft Tissue Sarcoma (EORTC: 62931) MORE... | Closed | |
|
SR.4 SWOG S0033 |
Phase III Randomized, Intergroup Trial Assessing the Clinical Activity of STI-571 at Two Dose Levels in Patients with Unresectable or Metastatic Gastrointestinal Stromal Tumours (GIST) Expressing the Kit Receptor Tyrosine Kinase (CD117) MORE... | Closed | |
|
SR.5 EORTC 62012 |
Randomized Trial of Single Agent Doxorubicin vs Doxorubicin/Ifosfamide/Neulasta in First Line Treatment of Advanced or Metastatic Soft Tissue Sarcoma MORE... | Closed | |
|
SRC.1 ACOSOG Z9001 |
A Phase III Randomized Double-Blind Study of Adjuvant STI571 GleevecTM versus Placebo in Patients Following the Resection of Primary Gastrointestinal Stromal Tumors (GIST) MORE... | Closed | |
|
SRC.5 SWOG S0502 |
A Phase III Randomized Study of Imatinib, with or without Bevacizumab (NSC-704865), in Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumors MORE... | Permanently Closed | |
| If you have any questions, comments or suggestions, please contact our |